Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal MNJ (Malang Neurology Journal) Narra J
Modesty, Kyra
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Zero-fluoroscopy versus fluoroscopy-guided catheter ablation in ventricular arrhythmia: A systematic review and meta-analysis Irnizarifka, Irnizarifka; Tristan, Christopher D.; Wijayanto, Matthew A.; Myrtha, Risalina; Modesty, Kyra; Rahma, Annisa A.; Budiono, Enrico A.; Rahman, Awalil R. K.; Hamka, Muhammad Farid; Ilyas, Muhana F.
Narra J Vol. 5 No. 2 (2025): August 2025
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narraj.v5i2.2094

Abstract

Catheter ablation has been the go-to treatment for ventricular arrhythmia, with traditional fluoroscopy-guided and non-zero fluoroscopy (NZF) catheter ablation posing high radiation risk for operators and patients. Zero-fluoroscopy technique offers elimination of radiation risk; however, its efficacy and safety in ventricular arrhythmia patients are not well explored. The aim of this study was to systematically evaluate the effectiveness, safety, and feasibility of zero-fluoroscopy ablation on ventricular arrhythmia patients. This study only included relevant studies comparing zero-fluoroscopy and NZF in ventricular arrhythmia ablation that were identified from Scopus, PubMed, and ScienceDirect (up to June 20, 2024). The quality of the study was assessed using the ROBINS-I tool, and the meta-analysis was conducted using a random-effect model. Out of 383 studies found, nine cohort studies were included with 1.408 patients. There was no significant difference in the acute procedural success rate of the zero-fluoroscopy and NZF (relative risk: 1.01; 95%CI: 0.95–1.07; p=0.69), with a similar recurrence rate (p=0.88; for four studies; n=374), and comparable procedural time (mean difference: -19.22 minutes; 95%CI: -41.16–2.72; p=0.09). Adverse events such as pericardial effusion, pseudoaneurysm, and hematoma were similar between zero-fluoroscopy and NZF. Overall, zero-fluoroscopy catheter ablation has demonstrated non-inferiority as a treatment option for ventricular arrhythmia ablation. As zero-fluoroscopy eliminates radiation risk without compromising procedural efficacy, zero-fluoroscopy has the potential to become a widely adopted approach for catheter ablation in ventricular arrhythmia.
EFFICACY OF ELECTRICAL STIMULATION (ES) ON DYSPHAGIA IN POST-STROKE PATIENTS: A SYSTEMATIC REVIEW Modesty, Kyra; Sitepu, Brigitta Ellycia; Budianto, Pepi; Probandari, Ari; Tandiyo, Desy Kurniawati
MNJ (Malang Neurology Journal) Vol. 11 No. 2 (2025): July
Publisher : PERDOSSI (Perhimpunan Dokter Spesialis Saraf Indonesia Cabang Malang) - Indonesian Neurological Association Branch of Malang cooperated with Neurology Residency Program, Faculty of Medicine Brawijaya University, Malang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mnj.2025.011.02.08

Abstract

Background: Stroke is a disease that can occur in both developed and developing countries and is the second leading cause of death in the world. Stroke can cause various complications such as dysphagia. This study examines the efficacy of electrical stimulation (ES) as a treatment for dysphagia in post- stroke patients with various measurements of the severity of dysphagia. Objective: This study aims to review the efficacy of electrical stimulation on dysphagia in post-stroke patients. Methods: This study uses a systematic review method by following the guidelines from PRISMA. Articles are arranged based on keywords that have been determined in PICO, namely electrical stimulation, dysphagia, and stroke. Articles included in the inclusion criteria are RCTs, in English, and published between January 2013 and January 2023. Results: Eighteen studies that met the inclusion criteria were critically reviewed by the two authors. There were ten types of outcomes included in this systematic review and six of them had significant results for reducing the severity of dysphagia. Conclusion: ES can be given as the main therapy for post-stroke dysphagia patients. The six types of outcomes used to measure the degree of dysphagia, namely FOIS, PAS, FDS, PTT, OTT, and MASA, showed high significance associated with a reduction in the degree of dysphagia thereby reducing the risk of aspiration pneumonia by using this ES therapy.
Co-Authors Ari Probandari Budianto, Pepi Budiono, Enrico A. Hamka, Muhammad Farid Ilyas, Muhana F. Irnizarifka Myrtha, Risalina Rahma, Annisa A. Rahman, Awalil R. K. Sitepu, Brigitta Ellycia Tandiyo, Desy Kurniawati Tristan, Christopher D. Wijayanto, Matthew A.